Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
UNIWERSYTET JAGIELLONSKI currently has 3 pending office actions distributed across its patent portfolio. These actions are located within the Biotechnology & Pharmaceuticals technology area. The prosecution involves 3 distinct examiners working across 3 distinct art units, showing the distribution of the current workload at the patent office.
BRIAN E MCDOWELL is identified as the busiest examiner for the portfolio, with 1 pending action under their review. This indicates that the 3 pending office actions are distributed among the 3 distinct examiners, as each examiner manages a single action. The involvement of 3 distinct art units further highlights the technical subject matter within the Biotechnology & Pharmaceuticals sector.
The presence of 3 pending office actions suggests active engagement with the patent office across multiple fronts. Practitioners should note that the 1 pending action assigned to BRIAN E MCDOWELL represents a portion of the total pending actions. This distribution across 3 distinct examiners and 3 distinct art units requires coordination across different examination groups.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCDOWELL, BRIAN E | 1 | 74.1% | +30.8% |
| SWIFT, CANDICE LEE | 1 | 57.5% | +36.0% |
| SPANGLER, JOSEPH RANKIN | 1 | 41.2% | +69.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18442296 | (E)-N-CINNAMOYLAMINOALKANOLS WITH MELANOGENESIS INHIBITORY ACTIVITY | MCDOWELL, BRIAN E | — |
| 17268596 | METHOD FOR CONJUGATION OF BIOMOLECULES AND NEW USE OF GOLD DONOR FOR BIOMOLECULAR COMPLEX FORMATION | SPANGLER, JOSEPH RANKIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18547256 | AN ARTIFICIAL TRAP-CAGE, ITS USE AND METHOD OF PREPARING THEREOF | SWIFT, CANDICE LEE | 4d overdue |
| 18442296 | (E)-N-CINNAMOYLAMINOALKANOLS WITH MELANOGENESIS INHIBITORY ACTIVITY | MCDOWELL, BRIAN E | — |
| 17268596 | METHOD FOR CONJUGATION OF BIOMOLECULES AND NEW USE OF GOLD DONOR FOR BIOMOLECULAR COMPLEX FORMATION | SPANGLER, JOSEPH RANKIN | — |
| Art Unit | Apps |
|---|---|
| 1624 | 1 |
| 1657 | 1 |
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18442296 | (E)-N-CINNAMOYLAMINOALKANOLS WITH MELANOGENESIS INHIBITORY ACTIVITY | MCDOWELL, BRIAN E | 1624 | §102§112 | Non-Final OA | — | Pending | Feb 15, 2024 |
| 18547256 | AN ARTIFICIAL TRAP-CAGE, ITS USE AND METHOD OF PREPARING THEREOF | SWIFT, CANDICE LEE | 1657 | §112 | Final Rejection | 4d overdue | Pending | Aug 21, 2023 |
| 17268596 | METHOD FOR CONJUGATION OF BIOMOLECULES AND NEW USE OF GOLD DONOR FOR BIOMOLECULAR COMPLEX FORMATION | SPANGLER, JOSEPH RANKIN | 1656 | §103§112Other | Final Rejection | — | Pending | Feb 16, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial